Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Long Ideas
  • Markets
  • Media
  • News
  • Top Stories
  • Trading Ideas

Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC’s ‘Final Trades’

By Avi Kapoor
June 5, 9:28 AM
Alphabet recently declared a $2 billion investment plan to establish its inaugural data center and Google Cloud region in Malaysia.

ASML

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Looking Into Ventas’s Recent Short Interest

By Benzinga Insights
May 9, 1:15 PM
Ventas’s (NYSE:VTR) short percent of float has risen 23.36% since its last report. The company recently reported that…

VTR

Read More
1 minute read
  • Guidance
  • News

Vertex Energy Q2 Outlook: Capex $20M-$25M, Direct Operating Expense/BBL $4.11-$4.46

By Benzinga Newsdesk
May 9, 6:04 AM
Management Outlook All guidance presented below is current as of the time of this release and is subject to change. All prior financial guidance should no longer be relied upon. Conventional

VTR

Read More
1 minute read
  • Guidance
  • News

Ventas Reiterates Guidance

By Benzinga Newsdesk
May 1, 4:15 PM
Full Year 2024 Guidance as of May 1, 20241Net Income and FFO Attributable to Common Stockholders2(In millions, except per share amounts; dollars in USD; totals may not sum due to rounding;

VTR

Read More
2 minute read
  • Dividends
  • Long Ideas
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

These 3 Real Estate Stocks With Over 4% Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts

By Avi Kapoor
May 1, 8:58 AM
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often…

EPRT

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

(VTR) – Analyzing Ventas’s Short Interest

By Benzinga Insights
March 29, 11:30 AM
Ventas’s (NYSE:VTR) short percent of float has risen 4.0% since its last report. The company recently reported that…

VTR

Read More
10 minute read
  • Earnings

Earnings Scheduled For February 14, 2024

By Benzinga Insights
February 14, 5:48 AM
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.

ACGL

Read More
3 minute read
  • Analyst Ratings

Forecasting The Future: 4 Analyst Projections For Ventas

By Benzinga Insights
January 16, 4:00 PM
Ventas (NYSE:VTR) has been analyzed by 4 analysts in the last three months, revealing a diverse range of…

VTR

Read More
1 minute read
  • Management
  • News

Ventas Confirms Issues Statement Regarding Three Director Nominations By Land & Buildings Investment Management

By Benzinga Newsdesk
January 11, 9:53 AM
No Shareholder Action Required at This TimeThe Ventas Board of Directors and management team are committed to acting in the best interests of the Company and all shareholders. Ventas shareholders today benefit from a

VTR

Read More
1 minute read
  • Long Ideas
  • Markets
  • Media
  • News
  • Trading Ideas

Jim Cramer Asks Why The World’s Largest Healthcare Products Company Has ‘An Ill-Advised Strategy’

By Lisa Levin
November 8, 9:35 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Clorox Company’s (NYSE: CLX) recent quarter was "ok." He added, "I think that the hack is behind them.

AGNC

Posts pagination

1 2 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service